ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
102,222.45
3.96%
S&P 500
5,975.38
0.55%
Dow Jones
42,706.56
-0.06%
US Dollar vs Yen
157.7615
0.16%
Brent Oil
76.115
-0.51%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ

  6. Harmony Biosciences Holdings Inc (HRMY) 銘柄情報

Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc (HRMY)

NASDAQ
34.50
-0.28
(-0.81%)
終値： 1月7日 6:00AM
15分遅延
34.50
0.00
( 0.00% )
取引時間後: 6:00AM
15分遅延

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

主要統計と詳細

通貨
34.50
買値
34.15
売値
34.92
出来高
375,312
34.21 日の範囲 35.03
28.14 52 週間の範囲 41.61
時価総額
1.968B
前日終値
34.78
始値
34.88
時刻
4115
@
34.5
(priorref)
最終取引時間
07:14:34
財務取引量
US$ 13,002,495
VWAP
34.6445
平均取引量 (3 か月)
747,819
発行済株式数
57,031,297
配当利回り
-
PER
15.27
1 株当たり利益 (EPS)
2.26
歳入
582.02M
純利益
128.85M

Harmony Biosciences Holdings Inc について

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The companys product WAKIX pitolisant is a molecule with a novel mechanism of action spe... Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The companys product WAKIX pitolisant is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
www.harmonybiosciences.com
本社
Wilmington, Delaware, USA
設立
-
Harmony Biosciences Holdings Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker HRMY. The last closing price for Harmony Biosciences was US$34.78. Over the last year, Harmony Biosciences shares have traded in a share price range of US$ 28.14 to US$ 41.61.

Harmony Biosciences currently has 57,031,297 shares in issue. The market capitalisation of Harmony Biosciences is US$1.98 billion. Harmony Biosciences has a price to earnings ratio (PE ratio) of 15.27.

HRMY 最新ニュース

その他のニュース

HARMONY BIOSCIENCES TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

HARMONY BIOSCIENCES TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE PR Newswire PLYMOUTH MEETING, Pa., Dec. 18, 2024 PLYMOUTH MEETING, Pa., Dec. 18, 2024 /PRNewswire/ -- Harmony...

2024年12月18日
PR Newswire (US)

HARMONY BIOSCIENCES TO PARTICIPATE IN OPPENHEIMER MOVERS IN RARE DISEASE SUMMIT

HARMONY BIOSCIENCES TO PARTICIPATE IN OPPENHEIMER MOVERS IN RARE DISEASE SUMMIT PR Newswire PLYMOUTH MEETING, Pa., Dec. 3, 2024 PLYMOUTH MEETING, Pa., Dec. 3, 2024 /PRNewswire/ -- Harmony...

2024年12月3日
PR Newswire (US)

HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES PR Newswire PLYMOUTH MEETING, Pa., Nov. 21, 2024 PLYMOUTH MEETING, Pa., Nov. 21, 2024 /PRNewswire/ -- Harmony Biosciences...

2024年11月21日
PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities

2024年11月6日
Edgar (US Regulatory)

Form 8-K - Current report

2024年11月2日
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

2024年11月1日
Edgar (US Regulatory)

Form 424B7 - Prospectus [Rule 424(b)(7)]

2024年11月1日
Edgar (US Regulatory)

Harmony Biosciences Holdings, Inc. Announces Pricing of Public Offering of Common Stock by Selling Shareholders

Harmony Biosciences Holdings, Inc. Announces Pricing of Public Offering of Common Stock by Selling Shareholders PR Newswire PLYMOUTH MEETING, Pa., Oct. 30, 2024 PLYMOUTH MEETING, Pa., Oct. 30...

2024年10月31日
PR Newswire (US)

Form 424B7 - Prospectus [Rule 424(b)(7)]

2024年10月30日
Edgar (US Regulatory)

Harmony Biosciences Holdings, Inc. Announces Commencement of Proposed Public Offering of Common Stock by Selling Shareholders

Harmony Biosciences Holdings, Inc. Announces Commencement of Proposed Public Offering of Common Stock by Selling Shareholders PR Newswire PLYMOUTH MEETING, Pa., Oct. 29, 2024 PLYMOUTH MEETING...

2024年10月30日
PR Newswire (US)
期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.541.5901060070733.9635.6733.362934744634.52964438CS
40.51.470588235293435.6731.61554457733.80550939CS
12-0.43-1.2310334955634.9341.6131.0574781934.03542687CS
262.57.81253241.6130.1757450134.6938596CS
521.895.7957681692732.6141.6128.1447496833.25615282CS
156-6.06-14.940828402440.5662.08518.611255276638.06852694CS
260-2-5.4794520547936.562.08518.611246459037.74870499CS

HRMY - Frequently Asked Questions (FAQ)

What is the current Harmony Biosciences share price?
The current share price of Harmony Biosciences is US$ 34.50
How many Harmony Biosciences shares are in issue?
Harmony Biosciences has 57,031,297 shares in issue
What is the market cap of Harmony Biosciences?
The market capitalisation of Harmony Biosciences is USD 1.98B
What is the 1 year trading range for Harmony Biosciences share price?
Harmony Biosciences has traded in the range of US$ 28.14 to US$ 41.61 during the past year
What is the PE ratio of Harmony Biosciences?
The price to earnings ratio of Harmony Biosciences is 15.27
What is the cash to sales ratio of Harmony Biosciences?
The cash to sales ratio of Harmony Biosciences is 3.38
What is the reporting currency for Harmony Biosciences?
Harmony Biosciences reports financial results in USD
What is the latest annual turnover for Harmony Biosciences?
The latest annual turnover of Harmony Biosciences is USD 582.02M
What is the latest annual profit for Harmony Biosciences?
The latest annual profit of Harmony Biosciences is USD 128.85M
What is the registered address of Harmony Biosciences?
The registered address for Harmony Biosciences is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Harmony Biosciences website address?
The website address for Harmony Biosciences is www.harmonybiosciences.com
Which industry sector does Harmony Biosciences operate in?
Harmony Biosciences operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
MSAIMultiSensor AI Holdings Inc
US$ 2.85
(42.50%)
2.56M
MCVTMill City Ventures III Ltd
US$ 3.04
(34.51%)
101.81k
XTIAXTI Aerospace Inc
US$ 0.1168
(32.73%)
377.71M
CDTConduit Pharmaceuticals Inc
US$ 0.0938
(29.74%)
17.08M
QRTEBQurate Retail Inc
US$ 3.13
(22.27%)
103
ENVBEnveric Biosciences Inc
US$ 0.3388
(-19.81%)
480.17k
AMSTAmesite Inc
US$ 3.45
(-14.81%)
60.67k
WATTEnergous Corporation
US$ 1.05
(-14.63%)
631.72k
SLRNACELYRIN Inc
US$ 2.9799
(-14.62%)
506.19k
ACXPAcurx Pharmaceuticals Inc
US$ 0.9401
(-13.75%)
166.52k
XTIAXTI Aerospace Inc
US$ 0.1168
(32.73%)
377.71M
SVMHSRIVARU Holding Ltd
US$ 0.0516
(11.45%)
30.11M
CRKNCrown Electrokinetics Corporation
US$ 0.1428
(7.37%)
29.76M
CEROCERo Therapeutics Holdings Inc
US$ 0.0468
(10.64%)
19.12M
CDTConduit Pharmaceuticals Inc
US$ 0.0938
(29.74%)
17.08M

HRMY Discussion

投稿を表示

最近閲覧した銘柄

NASDAQ
HRMY
Harmony Biosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有